Results 201 to 210 of about 19,560 (233)
Some of the next articles are maybe not open access.
TESTING INTRAVITREAL TOXICITY OF BEVACIZUMAB (AVASTIN)
Retina, 2006To evaluate the retinal toxicity of varying doses of bevacizumab when injected intravitreally in rabbits. Bevacizumab has been approved by the US Food and Drug Administration for the treatment of metastatic colorectal cancer.Twelve New Zealand albino rabbits were used for this study and divided into four groups.
Roberta P A, Manzano +3 more
openaire +2 more sources
Radiation maculopathy treated with intravitreal bevacizumab
Archivos de la Sociedad Española de Oftalmología (English Edition), 2017A 47 year-old woman with a choroidal melanoma developed a macular oedema secondary to radiation therapy 75 months after brachytherapy plaque. The patient received 3 intravitreal Bevacizumab injections.The patient had a good response to bevacizumab treatment.
J L, Sánchez-Vicente +6 more
openaire +2 more sources
Efficacy of intravitreal bevacizumab after unresponsive treatment with intravitreal ranibizumab
Canadian Journal of Ophthalmology, 2011To evaluate visual outcomes of eyes with choroidal neovascular membrane secondary to age-related macular degeneration that were initially treated with intravitreal ranibizumab then switched to intravitreal bevacizumab due to treatment failure.Retrospective chart review.Fifty eyes of 50 patients presenting to the Barnes Retina Institute.Patients ...
Arghavan, Almony +3 more
openaire +2 more sources
PREDICTED BIOLOGIC ACTIVITY OF INTRAVITREAL BEVACIZUMAB
Retina, 2007To create a time- and dose-dependent mathematical model that compares the intravitreal vascular endothelial growth factor (VEGF) binding activity of bevacizumab with that of ranibizumab.Intravitreal half-lives and relative equimolar VEGF binding activities of bevacizumab and ranibizumab were incorporated into a first-order decay model.
openaire +2 more sources
Progression of Macular Ischemia Following Intravitreal Bevacizumab
Ophthalmic Surgery, Lasers and Imaging Retina, 2009A 37-year-old woman with bilateral obliterative retinal vasculitis and macular ischemia received intravitreal bevacizumab for rapidly progressive neovascularization of the optic disc and vitreous hemorrhage in the left eye. One week after treatment, she presented with central scotoma and fluorescein angiography revealed increased ...
E Jason, Sabet-Peyman +5 more
openaire +2 more sources
Intravitreal Bevacizumab for Symptomatic Retinal Arterial Macroaneurysm
American Journal of Ophthalmology, 2013To evaluate the therapeutic effect of intravitreal bevacizumab injection for symptomatic retinal arterial macroaneurysm.Retrospective interventional case series.The study included 23 patients (23 eyes) with symptomatic retinal arterial macroaneurysm. They were categorized according to treatment method into 2 groups: an intravitreal bevacizumab-treated ...
Han Joo, Cho +6 more
openaire +2 more sources
ELECTROPHYSIOLOGIC FINDINGS AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENT
Retina, 2006To evaluate the short-term electrophysiologic effects of intravitreal bevacizumab in the treatment of exudative age-related macular degeneration (AMD).Nine subjects with AMD who received treatment with intravitreal bevacizumab for exudative AMD underwent pretreatment testing with multifocal electroretinography (mf-ERG) or Ganzfeld electroretinography ...
Raj K, Maturi +2 more
openaire +2 more sources
Intravitreal toxicity of bevacizumab
2019Roberta PA Manzano, Gholam A Peyman
openaire +1 more source